NCT03130348

Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: WITHDRAWN

Phase: PHASE2

Sponsor: Mayo Clinic

Condition: Amyloidosis, Immunoglobulin Light Chain Deposition

Signal summary

Status signal: Registry Stop Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: rare_population_signal | strict_eligibility_signal

Stopped reason

Study was dropped at site before participation